These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30357011)

  • 1. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?
    Chandramohan K; Balan DJ; Devi KP; Nabavi SF; Reshadat S; Khayatkashani M; Mahmoodifar S; Filosa R; Amirkhalili N; Pishvaei S; Sargazi-Aval O; Nabavi SM
    Eur J Pharmacol; 2023 Jun; 949():175699. PubMed ID: 37011722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways in colorectal cancer implications for the target therapies.
    Song Y; Chen M; Wei Y; Ma X; Shi H
    Mol Biomed; 2024 Jun; 5(1):21. PubMed ID: 38844562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Role of
    Li W; Li L; Yang H; Shi C; Lei Z; Guo L; Wang Y
    Front Biosci (Landmark Ed); 2024 Jul; 29(7):272. PubMed ID: 39082342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
    Hu S; Dai H; Li T; Tang Y; Fu W; Yuan Q; Wang F; Lv G; Lv Y; Fan X; Zhang S; Jin R; Shen Y; Lin F; Ye X; Ding M; Yang Y; Lei C
    Cancer Lett; 2016 Nov; 382(1):32-43. PubMed ID: 27569653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
    Fukuyama R; Niculaita R; Ng KP; Obusez E; Sanchez J; Kalady M; Aung PP; Casey G; Sizemore N
    Oncogene; 2008 Oct; 27(46):6044-55. PubMed ID: 18591935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights.
    Farooqi AA; de la Roche M; Djamgoz MBA; Siddik ZH
    Semin Cancer Biol; 2019 Oct; 58():65-79. PubMed ID: 30633978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
    Malki A; ElRuz RA; Gupta I; Allouch A; Vranic S; Al Moustafa AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic aspects of colorectal carcinogenesis].
    Gonciarz M; Pierzchalski P; Lorens K; Pawlik W; Petelenz M
    Wiad Lek; 2004; 57(1-2):74-9. PubMed ID: 15181754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.
    Li XL; Zhou J; Chen ZR; Chng WJ
    World J Gastroenterol; 2015 Jan; 21(1):84-93. PubMed ID: 25574081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).
    Ji Y; Lv J; Sun D; Huang Y
    Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34713301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photo-activated microtubule targeting drugs: Advancing therapies for colorectal cancer.
    Singh N; Sharma S
    World J Gastroenterol; 2024 Jul; 30(26):3257-3260. PubMed ID: 39086641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.